StockWatch
·
Biotechnology: Pharmaceutical Preparations
RegulatoryMay 28, 2026, 04:15 PM

CDT Equity Receives Nasdaq Notice for Late 10-Q Filing

AI Summary

CDT Equity Inc. announced it received a written notice from Nasdaq on May 21, 2026, for failing to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2026. This constitutes non-compliance with Nasdaq's Periodic Filing Requirement, though it does not immediately impact the company's listing or trading. CDT Equity has until July 20, 2026, to submit a plan to regain compliance and anticipates filing the Form 10-Q once its review process is complete.

Key Highlights

  • CDT Equity received a Nasdaq notice on May 21, 2026, for not timely filing its Q1 2026 Form 10-Q.
  • The non-compliance is with Nasdaq Listing Rule 5250(c)(1) (Periodic Filing Requirement).
  • The notice does not immediately affect the company's stock listing or trading.
  • CDT Equity has until July 20, 2026, to submit a plan to regain compliance.
  • The company expects to file its Form 10-Q soon to regain compliance.